Raymond James & Associates Novo Nordisk A S Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Novo Nordisk A S stock. As of the latest transaction made, Raymond James & Associates holds 3,526,821 shares of NVO stock, worth $308 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
3,526,821
Previous 3,507,198
0.56%
Holding current value
$308 Million
Previous $501 Million
16.12%
% of portfolio
0.26%
Previous 0.33%
Shares
30 transactions
Others Institutions Holding NVO
# of Institutions
1,957Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$1.76 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.26 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.25 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.16 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.07 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $197B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...